Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
KROS
NAGE
Add up to 3 more stocks
KROS
Keros Therapeutics, Inc.
-2.12%
$11.28-0.24Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$223.58M
52W Range
$9.69 - $22.55
NAGE
Niagen Bioscience Inc
+0.34%
$2.69+0.01Delayed quote: Oct 6, 2026, 12:50 PM EDT
Market Cap
$214.17M
52W Range
$2.61 - $7.95
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 14.43 |
| Forward P/E | N/A | 18.65 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 0.85 | 2.60 |
| P/S Ratio | 14.89 | 1.66 |
| P/FCF Ratio | N/A | 37.75 |
| EV/EBITDA | N/A | 14.35 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.7% | 64.2% |
| Operating Margin | 28.9% | 6.7% |
| Net Margin | -553.9% | 12.4% |
| ROE | -31.7% | 19.4% |
| ROA | -28.9% | 15.0% |
| ROIC | -36.5% | 8.8% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 21.96 | 6.50 |
| Quick Ratio | 21.96 | 5.13 |
| Debt/Equity | 0.06 | 0.03 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.